I love the variety of the types of writing and editing that I get to provide, and that I’m always learning about new advances in clinical research. It’s also great to be part of a fantastic team that is appreciative of my efforts....
I love the variety of the types of writing and editing that I get to provide, and that I’m always learning about new advances in clinical research. It’s also great to be part of a fantastic team that is appreciative of my efforts....
Read our article for an overview of early phase CAR-T studies in solid tumors....
Basket trials are a powerful tool in neuro-oncology, enabling the efficient study of rare and diverse CNS tumors. Learn about the benefits, potential imaging-related challenges, and possible solutions in our article....
Our sponsors are heavily invested in their clinical trials and are working in a very competitive environment. So, for them time is money, and MERIT is committed to providing data according to their timelines and needs, without sacrificing quality....
My expertise and passion lie in ophthalmic imaging and testing, making my role at the reading center a perfect fit. I play an active role in shaping the center’s involvement in major clinical trials, working closely with sponsors who seek guidance on the best imaging...
As soon as I joined MERIT, I was impressed by the culture here. Our team members support each other and often jump in to offer help when needed. We work hard to meet sponsors’ deadlines while ensuring data accuracy and completeness. ...
I oversee the daily operations of MERIT’s PM China team. We provide training and support for clinical sites, reading centers, and clients using EXCELSIOR™ and ensure study compliance for the lifecycle of a project....
Most brain cancer diagnoses in the United States are glioma, and MERIT’s webinar explored the challenges and potential solutions for assessing these tumors. New therapies are being studied through clinical trials, many of which use response criteria such as Response Assessment in Neuro-Oncology (RANO). This...
Idiopathic Pulmonary Fibrosis (IPF) is the most common type of PF, and its prevalence is on the rise globally. Numerous Phase 2 and Phase 2b/3 trials are underway for the development of new IPF treatments. ...
As General Manager, I’m responsible for global strategy alignment and localization execution for MERIT’s China team. Collaboration between business development, project management, and imaging quality control is crucial to our effective partnerships with Sponsors and CROs. ...
I am a certified CT/MRI Technologist and have over a decade of experience in Radiology. I love to share my knowledge base with my team and help out any way I can! I am so honored to be a part of the oncology research community....
I have been in the Ophthalmology field for 24 years. Being a Project Manager means interacting daily with many departments at MERIT as well as Sponsors, CROs, and sites. We work as a collective team to make sure that trials run as smoothly as possible...